Establishment of the National Biodefense Science Board, 34015 [07-3032]

Download as PDF Federal Register / Vol. 72, No. 118 / Wednesday, June 20, 2007 / Notices Anna McDonald Rentschler, BSA Officer, Central Bancompany, Jefferson City, Missouri Edna Sawady, Managing Director, Market Innovations, Inc., New York, New York Faith Arnold Schwartz, Senior Vice President, Enterprise Risk Management and Public Affairs, Option One Mortgage Corporation, Washington, District of Columbia Edward Sivak, Director of Policy and Evaluation, Enterprise Corporation of the Delta, Jackson, Mississippi H. Cooke Sunoo, Director, Asian Pacific Islander Small Business Program, Los Angeles, California Stergios ‘‘Terry’’ Theologides, Executive Vice President Corporate Affairs and General Counsel, New Century Financial Corporation, Irvine, California Linda Tinney, Vice President, Community Development West Metro Region Manager, U.S. Bank, Denver, Colorado Luz L. Urrutia, President and Chief Operating Officer, Banuestra Financial Corporation, Roswell, Georgia Alan White, Supervising Attorney, Community Legal Services, Philadelphia, Pennsylvania Board of Governors of the Federal Reserve System, June 14, 2007. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E7–11818 Filed 6–18–07; 8:45 am] BILLING CODE 6210–01–P FEDERAL RESERVE SYSTEM Sunshine Act Meeting Board of Governors of the Federal Reserve System. TIME AND DATE: 12:00 p.m., Monday, June 25, 2007. PLACE: Marriner S. Eccles Federal Reserve Board Building, 20th and C Streets, N.W., Washington, D.C. 20551. STATUS: Closed. MATTERS TO BE CONSIDERED: 1. Personnel actions (appointments, promotions, assignments, reassignments, and salary actions) involving individual Federal Reserve System employees. 2. Any items carried forward from a previously announced meeting. FOR FURTHER INFORMATION CONTACT: Michelle Smith, Director, or Dave Skidmore, Assistant to the Board, Office of Board Members at 202–452–2955. SUPPLEMENTARY INFORMATION: You may call 202–452–3206 beginning at rwilkins on PROD1PC63 with NOTICES AGENCY HOLDING THE MEETING: VerDate Aug<31>2005 18:25 Jun 19, 2007 Jkt 211001 approximately 5 p.m. two business days before the meeting for a recorded announcement of bank and bank holding company applications scheduled for the meeting; or you may contact the Board’s Web site at https:// www.federalreserve.gov for an electronic announcement that not only lists applications, but also indicates procedural and other information about the meeting. Board of Governors of the Federal Reserve System, June 15, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 07–3053 Filed 6–15–07; 4:10 pm] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Establishment of the National Biodefense Science Board Office of the Assistant Secretary for Preparedness and Response. ACTION: Notice. AGENCY: SUMMARY: The Office of the Secretary announces establishment of the National Biodefense Science Board. The Board will provide expert advice and guidance to the Secretary on scientific, technical and other matters of special interest to the Department of Health and Human Services regarding activities to prevent, prepare for and respond to adverse health effects of public health emergencies resulting from current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. Resumes or curricula vitae from qualified individuals who wish to be considered for membership on the Board are currently being accepted. To Submit a resume or curriculum vitae, send e-mail to nbsbnominations@hhs.gov. FOR FURTHER INFORMATION CONTACT: Dr. Susan Cibulsky at 202–260–7000 or nbsbquestions@hhs.gov. The Board’s charter and additional information may be accessed online at https:// www.hhs.gov/aspr/omsph/nbsb. SUPPLEMENTARY INFORMATION: Authority Section 402 of the Pandemic and AllHazards Preparedness Act (Pub. L. 109– 417) (codified at Section 319M of Title III of the Public Health Service Act (42 U.S.C. 247d–7f), as amended) directs the Secretary to establish the National Biodefense Science Board. PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 34015 Function The Board shall provide expert advice and guidance to the Secretary on scientific, technical, and other matters of special interest to the Department of Health and Human Services regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. Duties include, but are not limited to, (1) advising the Secretary on current and future trends, challenges, and opportunities presented by advances in biological and life sciences, biotechnology, and genetic engineering with respect to threats posed by naturally occurring infectious diseases and chemical, biological, radiological, and nuclear agents; (2) at the request of the Secretary, reviewing and considering any information and findings received from the working groups established under the authority of the Board; and (3) at the request of the Secretary, providing recommendations and findings for expanded, intensified, and coordinated biodefense research and development activities. Structure The Board shall consist of 13 voting members, including the Chairperson; additionally, there may be non-voting ex officio members. Members and the Chairperson shall be appointed by the Secretary from the among the Nation’s preeminent scientific, public health and medical experts, as follows: (a) Such Federal officials as the Secretary determines are necessary to support the functions of the Board; (b) four individuals from the pharmaceutical, biotechnology and device industries, (c) four academicians; (d) five other members as determined appropriate by the Secretary, one of whom must be a practicing health care professional and one of whom must be from an organization representing health care consumers. Additional members will be selected from among state and local governments, emergency medical responders, other components of the public health community, and organizations representing other appropriate stakeholders. Members shall be invited to serve overlapping threeyear terms. Unless renewed by appropriate action, the Board shall terminate five years after the date on which it was established. Dated: May 31, 2007. William C. Vanderwagon, Assistant Secretary for Preparedness and Response. [FR Doc. 07–3032 Filed 6–19–07; 8:45 am] BILLING CODE 4150–37–M E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 72, Number 118 (Wednesday, June 20, 2007)]
[Notices]
[Page 34015]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-3032]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Establishment of the National Biodefense Science Board

AGENCY: Office of the Assistant Secretary for Preparedness and 
Response.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Office of the Secretary announces establishment of the 
National Biodefense Science Board. The Board will provide expert advice 
and guidance to the Secretary on scientific, technical and other 
matters of special interest to the Department of Health and Human 
Services regarding activities to prevent, prepare for and respond to 
adverse health effects of public health emergencies resulting from 
current and future chemical, biological, nuclear, and radiological 
agents, whether naturally occurring, accidental, or deliberate. Resumes 
or curricula vitae from qualified individuals who wish to be considered 
for membership on the Board are currently being accepted.
    To Submit a resume or curriculum vitae, send e-mail to 
nbsbnominations@hhs.gov.

FOR FURTHER INFORMATION CONTACT: Dr. Susan Cibulsky at 202-260-7000 or 
nbsbquestions@hhs.gov. The Board's charter and additional information 
may be accessed online at https://www.hhs.gov/aspr/omsph/nbsb.

SUPPLEMENTARY INFORMATION: 

Authority

    Section 402 of the Pandemic and All-Hazards Preparedness Act (Pub. 
L. 109-417) (codified at Section 319M of Title III of the Public Health 
Service Act (42 U.S.C. 247d-7f), as amended) directs the Secretary to 
establish the National Biodefense Science Board.

Function

    The Board shall provide expert advice and guidance to the Secretary 
on scientific, technical, and other matters of special interest to the 
Department of Health and Human Services regarding current and future 
chemical, biological, nuclear, and radiological agents, whether 
naturally occurring, accidental, or deliberate. Duties include, but are 
not limited to, (1) advising the Secretary on current and future 
trends, challenges, and opportunities presented by advances in 
biological and life sciences, biotechnology, and genetic engineering 
with respect to threats posed by naturally occurring infectious 
diseases and chemical, biological, radiological, and nuclear agents; 
(2) at the request of the Secretary, reviewing and considering any 
information and findings received from the working groups established 
under the authority of the Board; and (3) at the request of the 
Secretary, providing recommendations and findings for expanded, 
intensified, and coordinated biodefense research and development 
activities.

Structure

    The Board shall consist of 13 voting members, including the 
Chairperson; additionally, there may be non-voting ex officio members. 
Members and the Chairperson shall be appointed by the Secretary from 
the among the Nation's preeminent scientific, public health and medical 
experts, as follows: (a) Such Federal officials as the Secretary 
determines are necessary to support the functions of the Board; (b) 
four individuals from the pharmaceutical, biotechnology and device 
industries, (c) four academicians; (d) five other members as determined 
appropriate by the Secretary, one of whom must be a practicing health 
care professional and one of whom must be from an organization 
representing health care consumers. Additional members will be selected 
from among state and local governments, emergency medical responders, 
other components of the public health community, and organizations 
representing other appropriate stakeholders. Members shall be invited 
to serve overlapping three-year terms. Unless renewed by appropriate 
action, the Board shall terminate five years after the date on which it 
was established.

    Dated: May 31, 2007.
William C. Vanderwagon,
Assistant Secretary for Preparedness and Response.
[FR Doc. 07-3032 Filed 6-19-07; 8:45 am]
BILLING CODE 4150-37-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.